LNCAROD and head and neck squamous cell carcinoma: METTL3‐mediated and METTL14‐mediated m6A modification enhances the stability of LNCAROD in head and neck squamous cell carcinoma (HNSCC) cells, an effect that is associated with the high expression of LNCAROD in HNSCC.37